MSH2 and Lynch syndrome: Lynch syndrome, defined by mutations causing inactivation of MMR genes, was found in 0.5% of cases (MLH1: 0.17%; MSH2: 0.03%; MSH6: 0.23%; and PMS2: 0.07%).